{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:22:39Z","timestamp":1767147759344,"version":"build-2238731810"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81500082"],"award-info":[{"award-number":["81500082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.leukres.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:32:19Z","timestamp":1508362339000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia"],"prefix":"10.1016","volume":"66","author":[{"given":"Jinjin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.10.004_bib0005","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","article-title":"Recent developments in myelodysplastic syndromes","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.004_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes\u2014coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.10.004_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-pathol-011811-132436","article-title":"Molecular pathophysiology of myelodysplastic syndromes","volume":"8","author":"Lindsley","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3321","article-title":"The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes","volume":"12","author":"Raza","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2017.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1078-0432.CCR-12-1251","article-title":"New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice","volume":"19","author":"Tothova","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2017.10.004_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/path.1711770212","article-title":"A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders","volume":"177","author":"Ohshima","year":"1995","journal-title":"J. Pathol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2012.02.014","article-title":"Evaluation of dysplasia through detailed cytomorphology in 3156 patientsfrom the D\u00fcsseldorf Registry on myelodysplastic syndromes","volume":"36","author":"Germing","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.10.004_bib0040","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2016-07-728766","article-title":"Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes","volume":"128","author":"Greenberg","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.004_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1984.tb02184.x","article-title":"Immunological study of in vitro maturation of human megakaryocytes","volume":"56","author":"Vinci","year":"1984","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1084\/jem.154.1.88","article-title":"Huamn megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes","volume":"154","author":"Rabellino","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2017.10.004_bib0055","first-page":"741","article-title":"Analysis of human hemopoietic progenitor cells for the expression of glycoprotein IIIa","volume":"16","author":"Kanz","year":"1988","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0060","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V80.12.3022.3022","article-title":"Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation","volume":"80","author":"Debili","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.004_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-016-0041-6","article-title":"A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes","volume":"5","author":"Feng","year":"2016","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1055\/s-0037-1613352","article-title":"Pathogenic effects of anti-glycoprotein Ib antibodies on megakaryocytes and platelets","volume":"88","author":"Alimardani","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.leukres.2017.10.004_bib0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/leu.2015.297","article-title":"Thrombocytopenia in MDS: epidemiology mechanisms, clinical consequences and novel therapeutic stratigies","volume":"30","author":"Li","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.10.004_bib0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2016-02-700054","article-title":"Time-dependent changes in mortality and transformation risk in MDS","volume":"128","author":"Pfeilst\u00f6cker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.10.004_bib0085","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2015.55","volume":"29","author":"Della Porta","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.10.004_bib0090","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2012.48.0764","volume":"31","author":"Voso","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1651-2227.2004.tb02708.x","article-title":"Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases","volume":"93","author":"Polychronopoulou","year":"2004","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.leukres.2017.10.004_bib0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3324\/haematol.2011.057158","article-title":"Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes","volume":"97","author":"Sandes","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.10.004_bib0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humpath.2012.05.022","article-title":"Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q)","volume":"44","author":"Geyer","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2016.04.009","article-title":"International Working Group on Morphology of MDS IWGM-MDS Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: difficulties in the assessment of dysplasia","volume":"45","author":"Goasguen","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.10.004_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000351272","article-title":"Dysplasia features of myelodysplastic syndrome in ethnically Chinese people","volume":"131","author":"Xiong","year":"2014","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.leukres.2009.02.011","article-title":"The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients","volume":"33","author":"Liu","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.10.004_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2016.04.009","article-title":"International Working Group on Morphology of MDS IWGM-MDS Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: difficulties in the assessment of dysplasia","volume":"45","author":"Goasguen","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.10.004_bib0130","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/jcp.38.11.1218","article-title":"Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological diagnostic, and prognostic features","volume":"38","author":"Fohlmeister","year":"1985","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2017.10.004_bib0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.13755","article-title":"Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach","volume":"94","author":"Bennett","year":"2009","journal-title":"Haematologica"}],"updated-by":[{"DOI":"10.1016\/j.leukres.2018.04.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000}}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T17:11:49Z","timestamp":1712337109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617305416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S0145212617305416"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.10.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}